Regenerative Medicine

Because articular cartilage has very limited intrinsic capacity to repair itself, regenerative medicine aims to restore or replace tissue that osteoarthritis has damaged [3]. Established cell therapies such as autologous chondrocyte implantation and its matrix-assisted variant are used for focal cartilage defects, although the broader problem of osteoarthritis remains harder to treat [3]. Mesenchymal stem cells have become a leading candidate, and intra-articular injection has induced hyaline-like cartilage regeneration through their trilineage potential, trophic effects and immunomodulatory properties [1]. The dose of cells, the joint environment and post-injection rehabilitation all influence how well repair proceeds [1].

Attention has also turned to the extracellular vesicles secreted by stem cells and joint tissues, which can dampen the inflammatory microenvironment and support cartilage repair while doubling as diagnostic biomarkers [2]. Engineering these vesicles, or combining them with biomaterials, is being explored to improve targeting and retention within the joint [2]. Synthetic-biology approaches that genetically programme cells to promote cartilage formation extend the toolkit still further [3]. Connecting these repair strategies to a mechanistic understanding of chondrocyte biology is where diagnostics and regeneration meet in Jessica's work [1].